A new method for discovering disease-specific MiRNA-target regulatory networks

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Baglioni, Miriam ^a   Russo, Francesco ^b,c   Geraci, Filippo ^a   Rizzo, Milena ^b   Rainaldi, Giuseppe ^b   Pellegrini, Marco ^b  

^a CNR   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; MICRORNA; SMALL UNTRANSLATED RNA; MESSENGER RNA;

3' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; CARDIOVASCULAR DISEASE; CELL INVASION; CELL PROLIFERATION; DEREGULATION; GENE CONTROL; GENE EXPRESSION; GENE INTERACTION; GENE REGULATORY NETWORK; HUMAN; IN VITRO STUDY; NEOPLASM; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; BIOLOGY; GENE EXPRESSION PROFILING; GENETICS; MALE; METABOLISM; PROCEDURES; PROSTATE TUMOR;

COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; MALE; MICRORNAS; PROSTATIC NEOPLASMS; RNA, MESSENGER;

EID: 84929493017     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122473     Document Type: Article

References (35)

1. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2000; 136(2):25-29.
2. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120(1):15-20. doi: 10.1016/j.cell.2004. 12.035 PMID: 15652477
3. Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008; 36(Database issue):D149-53. doi: 10.1093/nar/gkm995 PMID: 18158296
4. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E. The role of site accessibility in microRNA target recognition. Nat Genet. 2007; 39(10)1278-84. doi: 10.1038/ng2135 PMID: 17893677
5. Bisognin A, Sales G, Coppe A, Bortoluzzi S, Romualdi C. MAGIA2: from miRNA and genes expression data integrative analysis to microRNA-transcription factor mixed regulatory circuits (2012 update). Nucleic Acids Res. 2012; 40(Web Server issue):W13-21. doi: 10.1093/nar/gks460 PMID: 22618880
6. Alexiou P, Maragkakis M, Papadopoulos GL, Reczko M, Hatzigeorgiou AG. Lost in translation: an assessment and perspective for computational microRNA target identification. Bioinformatics. 2009; 25 (23):3049-55 doi: 10.1093/bioinformatics/btp565 PMID: 19789267
7. Muniategui A, Pey J, Planes FJ, Rubio A. Joint analysis of miRNA and mRNA expression data. Brief Bioinform. 2013; 14(3):263-78. doi: 10.1093/bib/bbs028 PMID: 22692086
8. Sethupathy P1, Megraw M, Hatzigeorgiou AG. A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods. 2006; 3(11):881-6. doi: 10.1038/ nmeth954 PMID: 17060911
9. Bentwich I. Prediction and validation of microRNAs and their targets. FEBS Lett. 2005; 579(26):5904-10 doi: 10.1016/j.febslet.2005.09.040 PMID: 16214134
10. Ideker T, Sharan R. Protein networks in disease. Genome Res. 2008; 18(4):644-52. doi: 10.1101/gr. 071852.107 PMID: 18381899
11. Jourquin J, Duncan D, Shi Z, Zhang B. GLAD4U: deriving and prioritizing gene lists from PubMed literature. BMC Genomics. 2012; 13(suppl.8):S20. doi: 10.1186/1471-2164-13-S8-S20 PMID: 23282288
12. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010; 18(1):11-22. doi: 10.1016/j.ccr.2010.05.026 PMID: 20579941
13. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene Ontology: tool for the unification of biology. Nat Genet. 2000; 25(1):25-29 doi: 10.1038/75556 PMID: 10802651
14. Chatr-Aryamontri A, Breitkreutz BJ, Heinicke S, Boucher L, Winter A, Stark C, et al. The BioGRID interaction database: 2013 update. Nucleic Acids Res. 2013; 41(Database issue):D816-23. doi: 10.1093/ nar/gks1158 PMID: 23203989
15. Koschtzki D, Lehmann KA, Peeters L, Richter S, Tenfelde-Podehl D, Zlotowski O. Centrality Indices. In Network Analysis: Methodological Foundations, Volume 3418 of LNCS Tutorial. Edited by Brandes U, Erlebach T. Springer. 2005;16-61.
16. Freeman LC. A set of measures of centrality based on betweenness. Sociometry. 1977; Vol. 40, No. 1, pp. 35-41 doi: 10.2307/3033543
17. Boldi P, Vigna S. Axioms for Centrality. Internet Mathematics. 2014
18. Hage P, Harary F. Eccentricity and centrality in networks. Social Networks. 1995; 17(1):57-63. doi: 10. 1016/0378-8733(94)00248-9
19. Bonacich P. Power and centrality: A family of measures. American journal of sociology. 1987; Vol. 92, No. 5, pp. 1170-1182. doi: 10.1086/228631
20. Lee I, Blom UM, Wang PI, Shim JE, Marcotte EM. Prioritizing candidate disease genes by networkbased boosting of genome-wide association data. Genome Res. 2011; 21(7):1109-21. doi: 10.1101/gr. 118992.110 PMID: 21536720
21. Mosteller F, Fisher RA. Questions and Answers, Answer number 14. The American Statistician. 1948; 2(5):30-31. doi: 10.2307/2681650
22. Tang Y, Yan W, Chen J, Luo C, Kaipia A, Shen B. Identification of novel microRNA regulatory pathways associated with heterogeneous prostate cancer. BMC Syst Biol. 2013; 7 Suppl 3:S6. doi: 10.1186/ 1752-0509-7-S3-S6 PMID: 24555436
23. Fu C, Dong WQ, Wang A, Qiu G. The influence of ESR1 rs9340799 and ESR2 rs1256049 polymor phisms on prostate cancer risk. Tumour Biol. 2014.
24. Hirata H, Ueno K, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL, et al. MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PloS one. 2013; 8(1):e55502. doi: 10.1371/journal.pone.0055502 PMID: 23383207
25. Wang L, Zou X, Berger AD, Twiss C, Peng Y, Li Y, et al. Increased expression of histone deacetylaces (HDACs) and inhibition of prostate cancer growth and invasion by HDAC inhibitor SAHA. Am J Transl Res. 2009; 1(1):62-71. PMID: 19966939
26. Liang T, Guo L, Liu C. Genome-wide analysis of mir-548 gene family reveals evolutionary and functional implications. J Biomed Biotechnol. 2012; 2012:679563. doi: 10.1155/2012/679563 PMID: 23091353
27. Piriyapongsa J, Jordan IK. A family of human microRNA genes from miniature inverted-repeat transposable elements. PLoS One. 2007; 2(2):e203. doi: 10.1371/journal.pone.0000203 PMID: 17301878
28. Liu Y, Lai L, Chen Q, Song Y, Xu S, Ma F, et al. MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN. J Immunol. 2012; 188(11):5500-10. doi: 10.4049/jimmunol.1103505 PMID: 22544933
29. Ries J, Vairaktaris E, Agaimy A, Kintopp R, Baran C, Neukam FW, et al. miR-186, miR-3651 and miR- 494: Potential biomarkers for oral squamous cell carcinoma extracted from whole blood. Oncol Rep. 2014; 31(3):1429-36. PMID: 24452363
30. Kwak SY, Yang JS, Kim BY, Bae IH, Han YH. Ionizing radiation-inducible miR-494 promotes glioma cell invasion through EGFR stabilization by targeting p190B RhoGAP. Biochim Biophys Acta. 2014; 1843(3):508-16. doi: 10.1016/j.bbamcr.2013.11.021 PMID: 24316134
31. Hsu SD, Tseng YT, Shrestha S, Lin YL, Khaleel A, Chou CH, et al. miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res. 2014; 42 (Database issue):D78-85. doi: 10.1093/nar/gkt1266 PMID: 24304892
32. Xiao J, Gong AY, Eischeid AN, Chen D, Deng C, Young CY, et al. miR-141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein. Prostate. 2012; 72(14):1514-22. doi: 10.1002/pros.22501 PMID: 22314666
33. Russo F, Di Bella S, Nigita G, Macca V, Laganà A, Giugno R, et al. miRandola: extracellular circulating microRNAs database. PLoS One. 2012; 7(10):e47786. doi: 10.1371/journal.pone.0047786 PMID: 23094086
34. Russo F, Di Bella S, Bonnici V, Laganà A, Rainaldi G, Pellegrini M, et al. A knowledge base for the discovery of function, diagnostic potential and drug effects on cellular and extracellular miRNAs. BMC Genomics. 2014; 15(3):1-7.
35. Fioretti FM, Sita-Lumsden A, Bevan CL, Brooke GN. Revising the role of the androgen receptor in breast cancer. J Mol Endocrinol. 2014; 52(3):R257-65. doi: 10.1530/JME-14-0030